Reviewed 4 November 2026. An official document can be authentic and still answer a different question from the one a reader has in mind. In discussions about novel foods, a catalogue entry, an application record, a scientific opinion and a legal authorisation are sometimes presented as interchangeable evidence. They are not.
This guide explains how to recognise those documents in an EU context, including Ireland. It is about reading evidence, not assessing an individual product or recommending consumption. EU documents should not be treated as a substitute for checking the relevant UK framework.
The Catalogue: orientation about novel-food status
The European Commission describes its Novel Food status Catalogue as non-binding and non-exhaustive. It offers orientation based on information from EU Member States. It is not a complete register of products permitted for sale.
The historical reference point is significant consumption as food in the EU before 15 May 1997. The detail matters: a history confined to food supplements does not establish the same position for other food uses. Intended use and technological function can also bring other legislation into view, while national restrictions may apply.
A missing search result therefore does not establish permission, and a familiar plant name does not settle the position of every material associated with that plant. Read the entry's description rather than drawing a conclusion from its heading alone.
The Union list: authorisation with boundaries
The Commission's Union list of authorised novel foods has a different purpose. Established through an implementing regulation, it brings together authorised novel foods, their specifications, conditions of use and labelling requirements. The Commission updates it as authorisations change.
An entry is more than an ingredient name. Specifications describe the material covered; conditions delimit the authorised uses. Authorisations are generally generic, although data-protection provisions can create exceptions. The relevant text and its amendments matter more than a cropped image showing one row.
Seeing an ingredient listed is not blanket approval of every finished product containing a similarly named substance. Nor does a novel-food authorisation, by itself, establish that a particular health claim is allowed. Our guide to reading the EU Health Claims Register explains that separate documentary question.
An application is a record of a request
A published application or application summary shows that an authorisation has been sought. It should not be read as a decision granting that authorisation.
The Commission's authorisations overview distinguishes the application from the later implementing act authorising market placement and updating the Union list. A reference number, submission date or administrative milestone is consequently not equivalent to that legal outcome.
When a document is offered as evidence, identify what it actually records. Is it a request, a scientific assessment or an adopted act? Those labels describe different events, even when all the documents concern the same material.
EFSA opinions: scientific assessment, not permission
The European Food Safety Authority evaluates safety. Its novel-food application overview, reviewed on 6 May 2026, separates scientific evaluation from the wider authorisation framework.
A scientific opinion must be read within its own scope: the material assessed, the evidence considered, the proposed uses and the uncertainties. A conclusion should not be detached from those boundaries. EFSA's assessment and the Commission's authorisation decision have different roles.
CBD illustrates why this distinction matters. In its 9 February 2026 update, EFSA described a provisional scientific conclusion with specific formulation boundaries and persistent data gaps. It also identified groups for whom safety could not be established. That update is not a general endorsement of CBD products or a personal intake recommendation. Individual applications remain tied to their supporting evidence.
For example, a news headline may accurately summarise one finding while leaving its qualifications in the full statement. A screenshot may preserve the wording but remove its date. Neither problem makes the original source unreliable; it means the shortened version is insufficient for the conclusion being drawn.
A short reading checklist
- Identify the issuing body and document type before interpreting the headline.
- Check the publication date, later amendments and whether the text is provisional.
- Match the material and intended use, not just a shared ingredient name.
- Keep scientific conclusions, legal decisions and marketing claims separate.
- Check jurisdiction: an EU source answers an EU question, not automatically a UK one.
The same discipline applies to laboratory paperwork. A composition result and a regulatory decision provide different kinds of evidence, as explained in our article on cannabinoid lab reports and European legal status.
Reliable reading starts with a modest question: what does this particular document establish? Keeping that question visible helps prevent a genuine official source from being used to support a claim broader than its contents.